Cardiovascular Disease: Valvular Heart Disease

sec_arr References
SECTIONS
  1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2020;143(5):e72-e227. Accessed June 18, 2023.
  2. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Heart Valve Dis. 1998;7(6):672-707. PMID: 9870202. Accessed 1/4/2023. 
  3. Gerkin R, Goldberg RL [2014]. Chapter I: Cardiovascular System. In: Medical Screening Manual for California Law Enforcement: Eds Goldberg RL; Weiss-Spilberg S, Weyers SG. At: https://post.ca.gov/portals/0/post_docs/publications/medical-screening-manual/Cardio.pdf?bookmark#evaluation%20of%20common%20clinical%20syndromes, accessed 1/2/2023.
  4. Thomas SL, Heaton J, Makaryus AN.  Physiology, cardiovascular murmurs.  StatPearls Publishing.  Treasure Island FL.  2023.  Accessed at https://www.ncbi.nlm.nih.gov/books/NBK525958/.  July 23, 2023.
  5. Blumenthal RS, Epstein AD, Kerber RE. Expert Panel Recommendations. Cardiovascular disease and commercial motor vehicle driver safety. Presented to Federal Motor Carrier Safety Administration April 10, 2007. At https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/Cardiovascular_Disease.pdf, accessed 1/3/2023.
  6. Connolly HM, Epstein AE, Kerber RE, Simpson C. Expert Panel Recommendations. Medical Examiner Physical Qualification Standards and Clinical Guidelines for Cardiovascular Disease and Commercial Motor Vehicle Driver Safety. Presented to Federal Motor Carrier Safety Administration June 5, 2013. At: https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/2020-04/FMCSA%20CVD%20MEP%20Recommendations%2005062013.pdf, date accessed 1/3/2023.
  7. Sabbag A, Essayagh B, Barrera JD, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022;24(12):1981-2003. Accessed 1/4/2023. 
  8. Essayagh B, Sabbag A, Antoine C. Presentation and outcome of arrhythmic mitral valve prolapse. J Am Coll Cardiol. 2020;76:637-49.
  9. Essayagh B, Sabbag A, Antoine C, et al. The mitral annular disjunction of mitral valve prolapse: presentation and outcome. JACC Cardiovasc Imaging. 2021;14:2073-87.
  10. Bouknight DP, O’Rourke RA. Current Management of Mitral Valve Prolapse. Am Fam Physician. 2000;61(11):3343-3350. Accessed 1/7/2023.
  11. AHVC (Asian Heart and Vascular Centre) [2016]. Mitral valve prolapse. At https://www.ahvc.com.sg/mitral-valve-prolapse-mvp/, accessed 1/7/2023.
  12. Bonow RO, Nishimura RA, Thompson PD, Udelson JE; American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e292–e297. Accessed 1/4/2023.